Form 6-K Adaptimmune Therapeutics For: Nov 13

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Form 6-K Adaptimmune Therapeutics For: Nov 13

Adaptimmune Therapeutics (ADAP) Narrows Q1 Loss

November 13, 2015 8:00 AM EST

Adaptimmune Therapeutics (NASDAQ: ADAP) reported Q1 EPS of $-0.00, versus (GBP0.01) reported last year. Revenue for the quarter came in at GBP2.6 million, versus GBP944 thousand reported last year.

Adaptimmune is reiterating its cash burn guidance. For the six months ending December... More